NEW YORK (GenomeWeb News) – Rubicon Genomics will integrate its ThruPlex technology into Diagenode's epigenetics platforms under a partnership announced today.

The deal is expected to result in improved efficiency and quality of DNA sample preparation for chromatin immunoprecipitation applications, Rubicon said.

Under the terms of the deal, Diagenode will incorporate the ThruPlex-FD technology into its MicroPlex Library Preparation Kit for ChIP-seq studies that require small sample amounts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.